My research focuses on understanding why individuals differ in their susceptibility to type 2 diabetes. I combine human genetics with clinical and molecular data to investigate how genetic variation shapes beta-cell function and metabolic health. My work aims to translate genetic insights into improved understanding of disease mechanisms and more personalised approaches to prevention and treatment.
I work with human genetics and clinical research in type 2 diabetes and metabolic disease. My work focuses particularly on genetic variation, beta-cell function and differences in metabolic disease development between individuals. I work with genetic and clinical data from both population-based cohorts and clinical studies to identify biological mechanisms and new opportunities for risk stratification and personalised treatment.